scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0009-9120(97)00004-0 |
P698 | PubMed publication ID | 9209792 |
P50 | author | Jacques Massé | Q58886370 |
Jean-Claude Forest | Q84761071 | ||
P2093 | author name string | J M Moutquin | |
P2860 | cites work | Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin | Q35218491 |
Maternal serum screening for Down's syndrome in early pregnancy | Q35703368 | ||
Antenatal maternal serum screening for Down's syndrome: results of a demonstration project | Q35823581 | ||
Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group. | Q38507170 | ||
First trimester serum screening for Down's syndrome | Q41034970 | ||
First-trimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. | Q45291831 | ||
Second‐trimester maternal serum screening using alpha‐fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: Experience of a regional programme | Q47339171 | ||
Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level | Q50148910 | ||
First trimester maternal serum pregnancy-associated plasma protein A and pregnancy-specific beta 1-glycoprotein in fetal trisomies. | Q64954668 | ||
Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropin | Q67673897 | ||
Screening for Down syndrome during the first and second trimesters: impact of risk estimation parameters | Q70787386 | ||
Serum PAPP-A measurements in first-trimester screening for Down syndrome | Q71610146 | ||
Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A, markers for fetal Down syndrome at 8-14 weeks | Q71639239 | ||
First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A | Q71670187 | ||
Serum PAPP-A and free beta-hCG are first-trimester screening markers for Down syndrome | Q71677716 | ||
Time-resolved immunofluorometric assay of pregnancy-associated plasma protein A in maternal serum screening for Down's syndrome in first trimester of pregnancy | Q71736128 | ||
Low maternal serum levels of pregnancy associated plasma protein A (PAPP‐A) in the first trimester in association with abnormal fetal karyotype | Q72080653 | ||
The use of free β‐hCG in antenatal screening for Down's syndrome | Q72087901 | ||
First‐trimester free beta (hCG) screening for Down syndrome | Q72099388 | ||
Serum PAPP‐A levels are depressed in women with fetal Down syndrome in early pregnancy | Q72099390 | ||
Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy | Q72772971 | ||
Maternal age-specific risks for trisomies at 9-14 weeks' gestation | Q72834367 | ||
P433 | issue | 4 | |
P921 | main subject | Down syndrome | Q47715 |
P304 | page(s) | 333-338 | |
P577 | publication date | 1997-06-01 | |
P1433 | published in | Clinical Biochemistry | Q5133749 |
P1476 | title | Screening for Down syndrome during first trimester: a prospective study using free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A | |
P478 | volume | 30 |
Q52941261 | Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study. |
Q34193225 | Down's syndrome screening: a controversial test, with more controversy to come! |
Q77848672 | Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency |
Q52252543 | Effect of repeated freeze-thaw cycles on maternal serum biological markers for the detection of fetal trisomies. |
Q33768998 | First trimester screening for aneuploidy: serum biochemical markers |
Q24187589 | First trimester serum tests for Down's syndrome screening |
Q34333074 | First-trimester biochemical screening for Down syndrome |
Q47328024 | Maternal serum screening for Down syndrome in the first trimester: experience from Belarus |
Q73083969 | The proform of eosinophil major basic protein: a new maternal serum marker for Down syndrome |
Search more.